Shenghuaxi Pharmaceutical

Chongqing Shenghuaxi Pharmaceutical Co., Ltd. was established in 1999. After more than 20 years of development, the company has become a high-tech enterprise integrating R&D, production and sales, with both active pharmaceutical ingredients (APIs) and pharmaceutical preparations.
The company takes R&D as its core competitiveness and has built a sizable scientific research system, with more than 400 full-time scientific and technological R&D personnel; the company invests about 10% of its sales revenue in R&D each year.
The company has two production bases, with more than ten sterile API and non-sterile API production workshops, 8 preparation workshops and more than 20 preparation production lines; it has an annual production capacity of more than RMB 2 billion for APIs and pharmaceutical preparations.
The company adopts multiple sales models, mainly agency sales. It has stationed marketing teams in provinces, municipalities, autonomous regions and municipalities directly under the Central Government across the country, providing distributors and customers with high-quality one-stop whole-process services.
In recent years, the company has developed nearly one hundred new drugs of APIs and pharmaceutical preparations, and has owned dozens of international patents and Chinese patents. The company has obtained more than 80 drug production approvals and has more than 10 projects under research each year. With its technology, high quality and low price, the company's products have an advantage in competition among domestic products of the same variety, and some APIs and preparations have been exported to the international market.
Shenghuaxi Pharmaceutical is committed to the discovery and cultivation of talent, allowing outstanding employees to realize their own value in the development of the enterprise. We sincerely look forward to the joining of outstanding talents in related professions to create the brilliance of Shenghuaxi together with us.